J Korean Pediatr Soc.  2001 Aug;44(8):942-947.

Two Cases of Growth Hormone Therapy in Idiopathic Dilated Cardiomyopathy

• Shin JW
• Kil HR
• Yu JH

Abstract

Growth hormone receptor gene is expressed in the myocardium and growth hormone(GH) administration has been shown to increase cardiac insulin-like growth factor-I(IGF-1) contents. The cardiac myocyte express IGF-I receptors and IGF-I promotes cardiac hypertrophy. Furthermore GH therapy has been reported to have beneficial effects in the treatment of dilated cardiomyopathy in adults. We have studied the effect of short term growth hormone treatment in two cases of a 5 year-old girl and a 15 year-old boy presenting idiopathic dilated cardiomyopathy. Transthoracic echocardiography revealed that the left ventricular chamber was markedly dilated and the global left ventricular systolic function was severely reduced in both. Medical treatments such as inotropic agents, diuretics and angiotensin converting enzyme(ACE) inhibitor were tried but we could not attain remarkable improvement. Finally, we started growth hormone treatment (0.35 U/kg/week, Eutropin, LGCI, Korea) and after treatment for 3 months, we attained a remarkable hemodynamic improvement in the 5 year-old girl with remarkable IGF-I increase after GH treatment, but not in the 15 year-old boy without IGF-I increase. The treatment was safe without side effects. However, no beneficial effects on cardiac function or structure were detected at 6 months of post-treatment.

Keyword

Idiopathic dilated cardiomyopathy; Growth hormone therapy

MeSH Terms

Adolescent
Adult
Angiotensins
Cardiomegaly
Cardiomyopathy, Dilated*
Child, Preschool
Diuretics
Echocardiography
Female
Growth Hormone*
Hemodynamics
Humans
Insulin-Like Growth Factor I
Male
Myocardium
Myocytes, Cardiac
Receptor, IGF Type 1
Receptors, Somatotropin
Angiotensins
Diuretics
Growth Hormone
Insulin-Like Growth Factor I
Receptor, IGF Type 1
Receptors, Somatotropin